News & Events

Latest Publications & Presentations

Publication
04/29/2021

The U.S. Food and Drug Administration (FDA) approved Makena® (hydroxyprogesterone caproate [HPC] injection) in February 2011 for reducing the risk of pre-term birth (PTB) in women with a singleton…

Publication
04/26/2021

We developed a three-component algorithm to identify patients aged ≥15 years who were newly diagnosed with Hodgkin (HL) or non-Hodgkin (NHL) lymphoma from January 2016 through July 2018 among…